News

Celgene UK has announced that preliminary clinical data from a phase III, randomized, double-blind study of elderly patients newly diagnosed with multiple myeloma, were presented during the 51st

Genomic Health has reported that The Lancet Oncology has published positive results from a study of Oncotype DX in postmenopausal women with node-positive, estrogen receptor-positive breast cancer. The

Proscape Technologies has reported that one of the largest pharmaceutical companies has deployed its new software platform as the key component of their global sales and marketing strategy.

Perceptive Informatics has launched product convergence between its DataLabs EDC solution and ClinPhone Randomisation and Trial Supply Management (RTSM) technologies. New functionality in the DataLabs EDC solution has

Cumberland Pharmaceuticals (Cumberland) has entered into an exclusive agreement with DB Pharm Korea for the commercialisation of Caldolor (ibuprofen) injection in South Korea. Designed to treat pain and

Atrium Medical has enrolled first patient in the Infuse AMI trial. Infuse AMI is a multi-center, multi-national, prospective, randomised, single blind trial, examining how patients with heart attacks

OvumOptics has introduced Ovu-Trac Ovulation Predictor Kit, which helps women increase their chances of conception, naturally, without medical intervention. The company said that Ovu-Trac kit uses saliva sampling

Hemodynamic has completed its initial Phase 2 clinical study of its compound (HTI-101), a patented low-dose small-molecule investigational therapy intended for patients with treatment-resistant hypertension. The 12-week double-blind

Perrigo has filed an Abbreviated New Drug Application (ANDA) for clobetasol propionate topical spray, 0.05%, a generic form of Clobex Spray. Clobex (clobetasol propionate) spray is indicated for